The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumors: experience from a national referral center in the United …

E Skoura, S Michopoulou… - Journal of Nuclear …, 2016 - Soc Nuclear Med
68Ga-DOTATATE PET/CT scanning is a widely accepted method for imaging of
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …

68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors

V Ambrosini, D Campana, L Bodei… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Several authors reported the superiority of 68Ga-DOTANOC PET/CT to conventional
imaging (CI) for the assessment of neuroendocrine tumors (NET). However, the detection of …

Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET/CT on clinical management in patients with neuroendocrine tumors

E Panagiotidis, A Alshammari… - Journal of Nuclear …, 2017 - Soc Nuclear Med
This study aimed to assess the clinical impact of 68Ga-DOTATATE and 18F-FDG with
respect to the management plan and to evaluate the prognostic value of both tracers …

Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors

J Ruf, F Heuck, J Schiefer, T Denecke, F Elgeti… - …, 2010 - karger.com
Aim: Retrospective evaluation of the impact of integrated positron emission
tomography/computed tomography (PET/CT) using 68Ga-DOTA (0)-Phe (1)-Tyr (3) …

Safety and efficacy of 68Ga-DOTATATE PET/CT for diagnosis, staging, and treatment management of neuroendocrine tumors

SA Deppen, E Liu, JD Blume, J Clanton… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Our purpose was to evaluate the safety and efficacy of 68Ga-DOTATATE PET/CT compared
with 111In-pentetreotide imaging for diagnosis, staging, and restaging of pulmonary and …

68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol

J Ruf, J Schiefer, C Furth, O Kosiek… - Journal of nuclear …, 2011 - Soc Nuclear Med
The diagnostic value of neuroendocrine tumor (NET) imaging using PET with integrated CT
is dependent on both components. This retrospective study assessed the value of the single …

Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT

Y Sanli, I Garg, A Kandathil, T Kendi… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to provide a review of the use of 68Ga
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …

Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors

D Wild, JB Bomanji, P Benkert, H Maecke… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Somatostatin receptor PET tracers such as [68Ga-DOTA, 1-Nal3]-octreotide (68Ga-
DOTANOC) and [68Ga-DOTA, Tyr3]-octreotate (68Ga-DOTATATE) have shown promising …

Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic …

DH Simsek, S Kuyumcu, C Turkmen… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Gastroenteropancreatic neuroendocrine tumors (GEPNETs) are indolent neoplasms
presenting unpredictable and unusual biologic behavior that causes many clinical …

The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors

AR Haug, R Cindea-Drimus… - Journal of nuclear …, 2012 - Soc Nuclear Med
In patients with suspected but yet not localized neuroendocrine tumors (NETs), early
diagnosis or reliable exclusion is crucial for optimal individual prognosis and therapy …